Nouvelle Veterinary, Inc., the makers of the Cur-OST® line of curcumin based anti-inflammatory products for horses, is investigating a new natural therapy in the management of insulin resistance in horses. 

Tom Schell, D.V.M., the creator of Cur-OST®, is seeking candidates for a small trial investigating the use of a new all natural product which has shown promising results in clinical practice in lowering insulin levels, reducing body weight and lowering lameness scores associated with laminitis. 

Insulin resistance is a common problem afflicting a high percentage of pleasure horses and is commonly referred to as metabolic syndrome.  These horses are generally overweight, have cresty necks and commonly have laminitis as a secondary problem.  The most common traditional therapies include dry lot confinement, increased exercise and low starch diets. 

Our current trials are indicating that this medical condition is associated with chronic inflammation, which may be controlled naturally with an overall improved quality of life and less restrictions for the equine patient.  Dr. Schell is seeking 10-15 additional candidates for his research study evaluating a new natural supplement that is top dressed onto the grain.  If you have an insulin resistant horse which may or may not have secondary laminitis, please contact Dr. Tom Schell via email at tschelldvm@gmail.com for further information and trial qualifications. Nouvelle Veterinary, Inc., where “Research Meets Health”.

For further information, please contact Dr. Tom Schell via email at tschelldvm@gmail.com or 1-800-476-4702.  Visit us online at www.curost.com.